Ubs Group Ag Clovis Oncology, Inc. Put Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 11, 2021	BUY	$4.13 - $6.41 $9,086 - $14,102	2,200 Added 1.47%	152,200 $731,000
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $196,500 - $767,500	50,000 Added 50.0%	150,000 $590,000
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $1.77 Million - $3.03 Million	100,000 New	100,000 $2.48 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.